The Medicines Company (NASDAQ: MDCO)
shares are currently trading at $12.47 a weekly gain of $3.00 which is 31.67%
up from last Tuesday’s closing price of $9.47. The company’s shares have
52-week trading range of $6.82 - $15.43. The daily average volume of the stock
is 12.79 million shares. The company has 50 day moving average of $8.17 and 200
day moving average of $8.08. The RSI of the stock is 87.18, showing an
overbought position of the stock. The sustenance and resistance levels of The
Medicines Company are $9.26 and $15.55. The Market Capitalization
of the company is $664.07 billion.
Subscribe to
daily free stock newsletter by visiting: http://www.PennyStockPickReport.com
Drug manufacturer Medicines Co. yesterday reported its second-quarter
results, net income rose to $15.4 million, or $0.29 per share, from $3.8
million, or $0.07 per share for the second quarter 2009. Income from operations
jumped to $16.58 million, from $6.13 million in the year ago quarter. Net
revenue increased to $110.1 million for the second quarter from $104.2 million
for the second quarter 2009.
Clive Meanwell, Chairman and Chief Executive Officer, stated, "In
the second quarter revenues reached record levels globally with market share
gains of the Angiomax/Angiox franchise in the U.S. and major European markets.
We also made progress with our development portfolio of three Phase 3 and two
earlier stage compounds. In addition, we continue to tighten expenditures with
the result that our net income was robust and we improved our cash position
substantially."
Analysts expected the company to report earnings of $0.23 per share on
revenues of $107.74 million for the quarter.
Subscribe to
daily free stock newsletter by visiting: http://www.PennyStockPickReport.com
Medicines Co. was trading in a narrow range of 9.20 - 9.70 for a week,
but jumped up sharply after
The Medicines Company (NASDAQ: MDCO) is focused on advancing the
treatment of critical care patients through the delivery of innovative,
cost-effective medicines to the worldwide hospital marketplace. The Company
markets Angiomax(R) (bivalirudin) in the
About http://www.PennyStockPickReport.com
Penny Stock Pick Report offers stock newsletter on OTC,
PINKSHEETS ,OTCBB, AMEX, NASDAQ and NYSE stock exchange. Our subscribers
receive daily up to date stock information on hot stocks, most active movers,
top gainers, penny stocks and much more. If you wish to feature your
organization on our website then you can contact us at the email given below.
